[go: up one dir, main page]

PE10597A1 - 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas - Google Patents

2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas

Info

Publication number
PE10597A1
PE10597A1 PE1996000045A PE00004596A PE10597A1 PE 10597 A1 PE10597 A1 PE 10597A1 PE 1996000045 A PE1996000045 A PE 1996000045A PE 00004596 A PE00004596 A PE 00004596A PE 10597 A1 PE10597 A1 PE 10597A1
Authority
PE
Peru
Prior art keywords
formula
linear
substituted
group
alcoxifenil
Prior art date
Application number
PE1996000045A
Other languages
English (en)
Inventor
Erwin Bischoff
Helmuth Schutz
Matthias Schramm
Ulrich Niewohner
Elisabeth Perzborn
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE10597A1 publication Critical patent/PE10597A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE REFIERE AL COMPUESTO DE FORMULA I, DONDE A=R1,R2,R3,R4 Y R5;R6,R7 Y R8 o -(CH2)a-CH3 SIENDO a=9,10,11,12,13,14 o 15. R1,R23 Y R24=ALQUILO LINEAL O RAMIFICADO SUSTITUIDO POR FENILO SUSTITUIDO POR UN GRUPO DE FORMULA -SO2-NR9R10, ENTRE OTROS; R9 Y R10 =H, FENILO, ENTRE OTROS; R2=H, AZIDO, ENTRE OTROS; R3=H;R2 Y R3 FORMAN UN RESTO DE FORMULA =0 o =N-OR20; R20=H, ENTRE OTROS; R7=ALQUILO LINEAL O RAMIFICADO SUSTITUIDO POR UN GRUPO DE FORMULA -NR23R24; R4,R5,R6 Y R8=H,ALQUILO LINEAL O RAMIFICADO. D=H O UN GRUPO DE FORMULA -SO2-NR27R28. E=ALQUILO LINEAL O RAMIFICADO CON HASTA 5 ATOMOS DE CARBONO Y SUS TAUTOMEROS Y SALES. TAMBIEN SE REFIERE AL PROCESO DE PREPARACION DE LA FORMULA I, QUE COMPRENDE LA CICLACION DE SUS SUSTITUYENTES A,E Y D. SE USA PARA EL TRATAMIENTO DE INFLAMACIONES, ENFERMEDADES TROMBOEMBOLICAS, CARDIACAS/CIRCULATORIAS
PE1996000045A 1995-01-19 1996-01-19 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas PE10597A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501480A DE19501480A1 (de) 1995-01-19 1995-01-19 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one

Publications (1)

Publication Number Publication Date
PE10597A1 true PE10597A1 (es) 1997-06-13

Family

ID=7751828

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000045A PE10597A1 (es) 1995-01-19 1996-01-19 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas

Country Status (30)

Country Link
US (1) US5866571A (es)
EP (1) EP0722943A1 (es)
JP (1) JPH08231546A (es)
KR (1) KR960029335A (es)
CN (1) CN1138583A (es)
AR (1) AR002704A1 (es)
AU (1) AU4097796A (es)
BG (1) BG61729B1 (es)
BR (1) BR9600149A (es)
CA (1) CA2167349A1 (es)
CO (1) CO4700524A1 (es)
CZ (1) CZ16896A3 (es)
DE (1) DE19501480A1 (es)
EE (1) EE9600020A (es)
FI (1) FI960226A7 (es)
HR (1) HRP960009A2 (es)
HU (1) HUP9600107A3 (es)
IL (1) IL116771A (es)
MA (1) MA23779A1 (es)
NO (1) NO960221L (es)
NZ (1) NZ280829A (es)
PE (1) PE10597A1 (es)
PL (1) PL312353A1 (es)
SG (1) SG47379A1 (es)
SK (1) SK7696A3 (es)
SV (1) SV1996000004A (es)
TN (1) TNSN96005A1 (es)
TR (1) TR199600701A2 (es)
YU (1) YU2896A (es)
ZA (1) ZA96399B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6064072A (en) * 1997-05-12 2000-05-16 Cymer, Inc. Plasma focus high energy photon source
DE19838300A1 (de) * 1998-08-24 2000-03-02 Bayer Ag 9-Dialkylaminopurinon-derivate
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
GB9924020D0 (en) 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
US7501409B2 (en) * 2000-09-06 2009-03-10 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
AU2002230217B2 (en) * 2001-02-15 2005-02-17 Tanabe Seiyaku Co., Ltd. Tablets quickly disintegrated in oral cavity
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
BR0207215A (pt) * 2001-12-13 2004-02-10 Daiichi Suntory Pharma Co Ltd Derivados de pirazolopiriminona tendo ação de inibição de pde7
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
JP2005527586A (ja) * 2002-04-05 2005-09-15 メルク エンド カムパニー インコーポレーテッド 置換アリールアミド
MX2016014384A (es) 2014-06-23 2017-01-20 Celgene Corp Apremilast para el tratamiento de una enfermedad del higado o una anormalidad en la funcion del higado.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents

Also Published As

Publication number Publication date
CN1138583A (zh) 1996-12-25
CA2167349A1 (en) 1996-07-20
KR960029335A (ko) 1996-08-17
NZ280829A (en) 1998-04-27
TR199600701A2 (tr) 1996-08-21
IL116771A0 (en) 1996-05-14
DE19501480A1 (de) 1996-07-25
HU9600107D0 (en) 1996-03-28
SK7696A3 (en) 1996-08-07
SV1996000004A (es) 1997-02-19
SG47379A1 (en) 1998-04-17
HUP9600107A2 (en) 1997-05-28
EE9600020A (et) 1996-08-15
HRP960009A2 (en) 1997-12-31
BR9600149A (pt) 1998-01-06
JPH08231546A (ja) 1996-09-10
US5866571A (en) 1999-02-02
FI960226A0 (fi) 1996-01-17
FI960226A7 (fi) 1996-07-20
AR002704A1 (es) 1998-04-29
NO960221L (no) 1996-07-22
ZA96399B (en) 1996-08-14
EP0722943A1 (de) 1996-07-24
TNSN96005A1 (en) 2005-03-15
PL312353A1 (en) 1996-07-22
IL116771A (en) 1999-06-20
AU4097796A (en) 1996-07-25
NO960221D0 (no) 1996-01-18
HUP9600107A3 (en) 1999-06-28
CO4700524A1 (es) 1998-12-29
BG61729B1 (bg) 1998-04-30
YU2896A (sh) 1999-03-04
MA23779A1 (fr) 1996-10-01
CZ16896A3 (en) 1996-08-14
BG100291A (bg) 1996-07-31

Similar Documents

Publication Publication Date Title
PE10597A1 (es) 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
ATE108187T1 (de) Protease-hemmer.
ES8106721A1 (es) Un metodo para la preparacion de derivados de ftalimidina
BR9006145A (pt) Material organico estabilizado contra dano provocado por luz,calor e oxigenio,bem como aplicacoes de compostos
DK160877C (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
ATE239619T1 (de) Aufzeichnungsmaterial sowie bilddruckverfahren das dieses material verwendet
MX169453B (es) Procedimiento para la preparacion de acidos alfa-arilcanoicos opticamente activos y sus intermediarios
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
FR2375213A1 (fr) Polyalkylpiperidines utilisables comme stabilisants de matieres plastiques
ATE93232T1 (de) Bis(methylendioxy)biphenyl-verbindungen.
MX9401209A (es) Derivados de 2-amido-4-feniltiazoles polisubstituidos.
SE7602144L (sv) Kvaternera imidazoliumforeningar
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
SE7605190L (sv) Nya tiazoliner
FI843354A0 (fi) Foerfarande foer framstaellning av nya 4-fenyl-4-oxo-2-ensmoersyraderivat.
AR012847A1 (es) Compuestos derivados de eritromicina, composiciones farmaceuticas, procedimientos de tratamiento con dichos compuestos, procedimiento parapreparar dichos compuestos
DE69123757D1 (de) Epoxysuccinamidsäurederivat
GR79170B (es)
FI883134A0 (fi) Fluorhaltiga renin-inhibitorer.
FI853685A0 (fi) Nya n-alk(en)yl-n-(o,o-disubstituerade -tiofosforyl)-n'n'-disubstituerade glycinamider, foerfarande foer framstaellning av dessa samt kvalstergifter, insektgifter och svampgifter vilka innehaoller dessa som aktiv bestaondsdel.
DK82583A (da) Furyloxazolyleddikesyrederivater og fremgangsmaader til fremstilling deraf
FI803706L (fi) Foerfarande foer framstaellning av alkyltiobenzimidazoler
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed